| 1 |
Saito M, Osa Y, Asakawa M. Antibodies to flaviviruses in wild ducks captured in Hokkaido, Japan: risk assessment of invasive flaviviruses. Vector Borne Zoonotic Dis 2009;9:253-8.
DOI
|
| 2 |
Kwak BO, Hong HJ, Kim DH. Changes in age-specific seroprevalence of Japanese encephalitis virus and impact of Japanese encephalitis vaccine in Korea. Clin Exp Pediatr 2022;65:108-14.
DOI
|
| 3 |
Campbell GL, Hills SL, Fischer M, Jacobson JA, Hoke CH, Hombach JM, et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ 2011;89:766-74, 774A-774E.
DOI
|
| 4 |
World Health Organization. Japanese encephalitis vaccines: WHO position paper. Wkly Epidemiol Rec 2015;90:69-87.
|
| 5 |
Connor B, Bunn WB. The changing epidemiology of Japanese encephalitis and new data: the implications for new recommendations for Japanese encephalitis vaccine. Trop Dis Travel Med Vaccines 2017;3:14.
DOI
|
| 6 |
Bae W, Kim JH, Kim J, Lee J, Hwang ES. Changes of epidemiological characteristics of Japanese encephalitis viral infection and birds as a potential viral transmitter in Korea. J Korean Med Sci 2018;33:e70.
DOI
|
| 7 |
Arai S, Matsunaga Y, Takasaki T, Tanaka-Taya K, Taniguchi K, Okabe N, et al. Japanese encephalitis: surveillance and elimination effort in Japan from 1982 to 2004. Jpn J Infect Dis 2008;61:333-8.
|
| 8 |
Lee EJ, Cha GW, Ju YR, Han MG, Lee WJ, Jeong YE. Prevalence of neutralizing antibodies to Japanese encephalitis virus among high-risk age groups in South Korea, 2010. PLoS One 2016;11:e0147841.
DOI
|
| 9 |
Kwak BO, Kwon YS, Hong YJ, Nahm CH, Jang W, Uh Y, et al. Seroprevalence of neutralizing antibodies against Japanese encephalitis virus among adolescents and adults in Korea: a prospective multicenter study. Vaccines (Basel) 2020;8:328.
DOI
|
| 10 |
Hsu LC, Chen YJ, Hsu FK, Huang JH, Chang CM, Chou P, et al. The incidence of Japanese encephalitis in Taiwan--a population-based study. PLoS Negl Trop Dis 2014;8:e3030.
DOI
|
webmaster
